These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 37033265)

  • 21. SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism.
    Martinelli S; Riverso M; Mello T; Amore F; Parri M; Simeone I; Mannelli M; Maggi M; Rapizzi E
    Mol Cell Endocrinol; 2022 May; 547():111594. PubMed ID: 35149119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
    Eisenhofer G; Lenders JW; Siegert G; Bornstein SR; Friberg P; Milosevic D; Mannelli M; Linehan WM; Adams K; Timmers HJ; Pacak K
    Eur J Cancer; 2012 Jul; 48(11):1739-49. PubMed ID: 22036874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
    Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
    PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary Diseases Predisposing to Pheochromocytoma (VHL, NF-1, Paraganglioma Syndromes, and Novel Genes).
    Sarkadi B; Patócs A
    Exp Suppl; 2019; 111():129-147. PubMed ID: 31588531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
    Ilanchezhian M; Jha A; Pacak K; Del Rivero J
    Curr Treat Options Oncol; 2020 Aug; 21(11):85. PubMed ID: 32862332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
    Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rare case of multiple paragangliomas in the head and neck, retroperitoneum and duodenum: A case report and review of the literature.
    Kawanabe S; Katabami T; Oshima R; Yanagisawa N; Sone M; Kimura N
    Front Endocrinol (Lausanne); 2022; 13():1054468. PubMed ID: 36704041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
    Rai SK; Bril F; Hatch HM; Xu Y; Shelton L; Kalavalapalli S; Click A; Lee D; Beecher C; Kirby A; Kong K; Trevino J; Jha A; Jatav S; Kriti K; Luthra S; Garrett TJ; Guingab-Cagmat J; Plant D; Bose P; Cusi K; Hromas RA; Tischler AS; Powers JF; Gupta P; Bibb J; Beuschlein F; Robledo M; Calsina B; Timmers H; Taieb D; Kroiss M; Richter S; Langton K; Eisenhofer G; Bergeron R; Pacak K; Tevosian SG; Ghayee HK
    Metabolism; 2020 Sep; 110():154297. PubMed ID: 32562798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
    Moraitis AG; Martucci VL; Pacak K
    Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.
    Muth A; Abel F; Jansson S; Nilsson O; Ahlman H; Wängberg B
    World J Surg; 2012 Jun; 36(6):1389-94. PubMed ID: 22270996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New advances in the genetics of pheochromocytoma and paraganglioma syndromes.
    Gimenez-Roqueplo AP
    Ann N Y Acad Sci; 2006 Aug; 1073():112-21. PubMed ID: 17102078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
    Benn DE; Richardson AL; Marsh DJ; Robinson BG
    Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas?
    Iacobone M; Schiavi F; Bottussi M; Taschin E; Bobisse S; Fassina A; Opocher G; Favia G
    Surgery; 2011 Dec; 150(6):1194-201. PubMed ID: 22136840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic Landscape of Pheochromocytoma and Paraganglioma.
    Jochmanova I; Pacak K
    Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Jazbec T; Girod PP; Url C; Thomé C; Riechelmann H; Sprinzl GM; Fraedrich G; Virgolini IJ
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):94-99. PubMed ID: 30630744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
    Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
    Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.
    Fishbein L; Khare S; Wubbenhorst B; DeSloover D; D'Andrea K; Merrill S; Cho NW; Greenberg RA; Else T; Montone K; LiVolsi V; Fraker D; Daber R; Cohen DL; Nathanson KL
    Nat Commun; 2015 Jan; 6():6140. PubMed ID: 25608029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.